BioLife Solutions Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,703	1,165	1,218	734	780	1,559
Market Cap Growth	56.74%	-4.29%	65.91%	-5.85%	-49.98%	18.26%
Enterprise Value	1,606	1,094	1,147	723.61	760.56	1,516
Last Close Price	34.82	24.18	25.96	16.25	18.20	37.27
PE Ratio	35.31	-	-	-	1820.00	-
Forward PE	121.45	299.08	223.59	223.59	223.59	223.59
PEG Ratio	-	22.36	22.36	22.36	22.36	22.36
PS Ratio	15.96	12.11	16.31	10.79	10.23	13.08
PB Ratio	4.05	3.13	3.49	2.17	2.14	3.26
P/TBV Ratio	8.23	7.40	8.88	6.27	7.30	14.19
P/FCF Ratio	223.10	109.57	233.99	-	-	-
P/OCF Ratio	100.90	57.94	144.43	-	-	-
EV/Sales Ratio	15.05	11.37	15.37	10.64	9.98	12.72
EV/EBITDA Ratio	-	-	274.14	-	72.10	-
EV/FCF Ratio	210.35	102.89	220.41	-	-	-
Debt / Equity Ratio	0.03	0.03	0.05	0.08	0.11	0.05
Debt / EBITDA Ratio	-	-	7.18	-	4.14	-
Debt / FCF Ratio	-	1.68	5.77	-	-	-
Net Debt / Equity Ratio	-0.16	-0.19	-0.20	-0.03	-0.05	-0.09
Net Debt / EBITDA Ratio	1.61	5.96	-16.90	2.11	-1.80	1.93
Net Debt / FCF Ratio	25.01	-6.68	-13.58	0.55	1.01	3.31
Asset Turnover	0.07	0.24	0.18	0.16	0.15	0.30
Inventory Turnover	0.31	1.15	0.87	0.86	0.93	4.11
Quick Ratio	5.91	3.87	3.08	1.23	2.17	2.18
Current Ratio	9.69	5.94	4.54	2.86	3.11	2.95
Return on Equity (ROE)	12.74%	-3.37%	-2.56%	-3.46%	0.09%	-14.10%
Return on Assets (ROA)	0.41%	-4.13%	-1.10%	-3.96%	-2.62%	-15.30%
Return on Invested Capital (ROIC)	0.53%	-5.75%	-1.47%	-5.08%	-3.38%	-21.52%
Return on Capital Employed (ROCE)	-10.97%	-4.43%	-1.21%	-4.43%	-1.29%	-9.62%
Earnings Yield	3.40%	-	-	-	0.05%	-
FCF Yield	0.45%	0.91%	0.43%	-	-	-
Buyback Yield / Dilution	-5.54%	-5.60%	-5.37%	-1.50%	-11.87%	-41.01%
Total Shareholder Return	-5.54%	-5.60%	-5.37%	-1.50%	-11.87%	-41.01%

SEC Filings: 10-K · 10-Q